{
  "docId": "019dd923-5fed-74f2-a96f-6b553a5d9cee",
  "docSlug": "bi-b4800d178bbbc7a4",
  "documentTitle": "ImCheck Therapeutics pitch deck used to raise Series C",
  "authorId": "Pitchdecks",
  "authorName": "ImCheck Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.331,
  "pageNumber": 5,
  "pageCount": 14,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "context",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses two distinct charts: a stacked bar chart for relative abundance across cancer types and a horizontal bar chart for survival correlation (meta-z scores).",
  "elementsJson": [
    "action_title",
    "bar_chart_stacked",
    "bar_chart_horizontal",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a96f-6b553a5d9cee/5",
  "deckHref": "/decks/019dd923-5fed-74f2-a96f-6b553a5d9cee",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a96f-6b553a5d9cee.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a96f-6b553a5d9cee#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.26,
        "x": 0.715,
        "y": 0.22
      },
      "kind": "callout",
      "text": "Unique Features of γδ2 T Cells: Infiltrate most tumors, Correlated with favorable prognosis, Dual effect (lysis & immune response), No MHC restriction",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c501d62e-c0b8-4914-989c-29248a9f17d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "A dual effect: direct tumor lysis & immune response enhancement through cytokine production (IFNγ, TNFα) and antigen presentation capability to bridge to adaptive immunity",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c5b1-7611-ab2d-9ee622b24817",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.58,
        "x": 0.12,
        "y": 0.48
      },
      "kind": "chart",
      "text": "Pan-cancer survival correlation (meta-z)",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c5d315c-9e43-4e88-a769-3f5b278674f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.68,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Relative abundance of immune cells across hematologic and solid tumors",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7efd9ddb-e3ad-48cb-8e38-54d66b1cfb1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Relative abundance",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-c5b1-7611-ab2d-a11d1db00593",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.02,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Adapted from Tosolini et al, OncoImmunol, 2017 and Gentles et al, Nat Med, 2015",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a074ed7a-fb59-4a59-a20e-3d36a896d27b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "γδ T Cells: Tumor Infiltrating Immune Population to Target in I/O",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37de8301-90c2-4e37-81d3-f0e3eabe15e1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "eac51234-9a34-48a2-aefe-558e31387e21",
      "evidence": "Slides 4-5 emphasize recent developments and the potential of γδ T Cells",
      "position": 0,
      "objective": "Highlight the importance of γδ T Cells in cancer treatment",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}